Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of central nervous system (CNS) drugs. Its structural motif supports binding to neurotransmitter transporters, making it valuable in the production of antidepressants and anticonvulsants. The compound’s stereochemistry enhances selectivity and potency in drug candidates targeting monoamine reuptake inhibition. It is also employed in research settings for designing novel bioactive molecules and optimizing pharmacokinetic profiles in lead compounds.